Using Korecyte’s HypoxiCAR platform we are preparing to initiate our first in human Phase I trial for cancer with our lead clinical candidate KOR101.
Using Korecyte’s HypoxiCAR platform we are preparing to initiate our first in human Phase I trial for cancer with our lead clinical candidate KOR101.